About
The Company
Our Heritage
Mission & Vision
Expertise
Services
Products
Investor relations
Financial Information
Annual Financials
FY18
FY19
FY20
FY21
FY22
Quarterly Results
Quarterly Results 21-22
Financial Results Q1(April- June)
Financial Results Q2(July- Sep)
Financial results Q3 (Oct- Dec)
Financial results Q4 (Jan- Mar)
Quarterly Results 22-23
Financial Results Q1(April- June)
Financial Results Q2(July-Sep)
Financial Results Q3(Oct-Dec)
Investor Presentation
Result Presentation FY 21-22
Result Presentation Q1
Result Presentation Q2
Result Presentation Q3
Result Presentation Q4
Result Presentation FY 22-23
Q1 FY 22-23
Q2 FY 22-23
Q3 FY 22-23
Quarterly results press release
Earnings Call Transcript
Audio Transcript
FY 21-22
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
FY 22-23
Q1
Q2
Q3
Annual Report
21st AGM Transcript
FY 21-22
Buy Back of Shares
Public Announcement
Daily Reporting
Extinguishment of Shares
Corporate Governance
Committee Composition
LIST OF DIRECTORS
Independent Directors
Audit Committee Charter
CSR Committee Charter
Stakeholder Relationship Committee Charter
Nomination and Remuneration Committee Charter
Terms and Conditions for appointment of Independent Director
Management Team Information
Code of Conduct
Policies
Annual Return
Annual Return FY 20-21
Annual Return FY 21-22
Credit Rating
Investor information
Company Fact sheet
Shareholding Pattern
Stock Price
Corporate Announcements
Notice of Board Meeting
Invites and Others
Stock Exchange Communication
Certificate under Reg 74(5)
Monitoring Agency
Statement of Deviation
SECRETARIAL COMPLIANCE REPORT
Schedule of Analysts
PUBLISHED IN NEWSPAPER
Investor Contact
Compliance Officer
Investor Relations
Registrar
Grievance Officer
Contact for Material Events
CSR
Career
Contact
Search
GRIEVANCE OFFICER
Mr. Ananta Narayan Panda
grievance@windlasbiotech.com
Privacy Preference Center
Privacy Preferences
